Novel P4 truncated tripeptidyl α-ketoamides as HCV protease inhibitors
- 1 January 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (1) , 263-266
- https://doi.org/10.1016/j.bmcl.2003.09.076
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- P1 and P3 optimization of novel bicycloproline P2 bearing tetrapeptidyl α-ketoamide based HCV protease inhibitorsBioorganic & Medicinal Chemistry Letters, 2004
- Emerging therapies for hepatitis C virus infectionEmerging Drugs, 2001
- Efficient Initiation of HCV RNA Replication in Cell CultureScience, 2000
- α-Ketoamides, α-ketoesters and α-diketones as HCV NS3 protease inhibitorsBioorganic & Medicinal Chemistry Letters, 2000
- Novel Approaches to the Treatment of Hepatitis C Virus InfectionAntiviral Chemistry and Chemotherapy, 2000
- Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell LineScience, 1999
- The diisopropylcarbodiimide/ 1-hydroxy-7-azabenzotriazole system: Segment coupling and stepwise peptide assemblyTetrahedron, 1999
- Hepatitis C virus NS3/4A proteaseAntiviral Research, 1998
- A Concise, Stereocontrolled Thiazolium Ylide Approach to Kainic AcidThe Journal of Organic Chemistry, 1994
- PyBOP®: A new peptide coupling reagent devoid of toxic by-productTetrahedron Letters, 1990